BET BRD inhibitor,cas 1505453-59-7|DC CHEM

Cas No.:	1505453-59-7
SMILES:	O=C(N)C[C@@H]1N=C(C2=CC=C(Cl)C=C2)C3=CC(C4=CN(C)N=C4)=CC=C3C5=C1ON=C5C
Formula:	C₂₄H₂₀ClN₅O₂
M.Wt:	445.9
Purity:	>98%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Description:

A new compound which is similar with +JQ-1，BET bromodomain inhibitor. For the detailed information of BET bromodomain inhibitor,cas 1505453-59-7, the solubility of BET bromodomain inhibitor,cas 1505453-59-7 in water, the solubility of BET bromodomain inhibitor,cas 1505453-59-7 in DMSO, the solubility of BET bromodomain inhibitor,cas 1505453-59-7 in PBS buffer, the animal experiment (test) of BET bromodomain inhibitor,cas 1505453-59-7, the cell expriment (test) of BET bromodomain inhibitor,cas 1505453-59-7, the in vivo, in vitro and clinical trial test of BET bromodomain inhibitor,cas 1505453-59-7, the EC50, IC50,and Affinity of BET bromodomain inhibitor,cas 1505453-59-7, Please contact DC Chemicals.

Cat. No.	Product name	Field of application
DC10190	TPOP146	TPOP146 is a selective CBP/P300 benzoxazepine bromodomain inhibitor with Kd values of 134 nM and 5.02 μM for CBP and BRD4.
DC11041	QCA276	QCA276 is a novel potent BET proteins inhibitor with IC50/Ki of 10/.3 nM, QCA276 is the BET ligand for PROTAC QCA570.
DC12248	PROTAC BET degrader-2	PROTAC BET degrader-2 is a highly potent degrader of Bromodomain and Extra-Terminal (BET) proteins with an IC50 value of 9.6 nM in cell growth inhibition in the RS4;11 cells and capable of achieving tumor regression.
DC11063	MS645	MS645 (MS-645) is a novel, bivalent bromodomain (BRD) inhibitor with Ki of 18.4 nM for tandem BD1-BD2 (BRD4 BD1/BD2 ), shows12- to 28-fold gain in affinity for binding to the tandem BD1-BD2 over the single BD1 or BD2.
DC12313	GNE-371	GNE-371 is a potent and selective chemical probe for the second bromodomains of human transcription-initiation-factor TFIID subunit 1 and transcription-initiation-factor TFIID subunit 1-like, with an IC50 of 10 nM for TAF1(2).
DC9934	GNE-272	GNE-272 is a in Vivo Probe for the Bromodomains of CBP/EP300.
DC8556	BET-BAY 002	BET-BAY 002 is a potent BET inhibitor; shows efficacy in a multiple myeloma model.
DC11042	BET inhibitor CF53	BET inhibitor CF53 is a highly potent, orally active inhibitor of bromodomain and extra-terminal (BET) with Ki of <1 nM (BRD4 BD1).
DC7854	BAZ2-ICR	BAZ2-ICR is a selective BAZ2 bromodomain inhibitor (Kd values are 109 and 170 nM for BAZ2A and BAZ2B respectively).
DC11568	HJB-97	A potent BET bromodomian inhibitor with IC50 of 3-7 nM for BRD2/3/4 BD1 and BD2..